Search for: "Matter of Lilly"
Results 321 - 340
of 740
Sorted by Relevance
|
Sort by Date
22 Jun 2018, 3:18 am
The guide is authored by Michael Edenborough QC - who has appeared in over 275 matters before the UK registry and over 60 appeals before the Appointed Person. [read post]
23 Jan 2013, 1:55 pm
Eli Lilly, the 2010 en banc Federal Circuit decision that reaffirmed that the written description requirement is separate from enablement, which is probably the first case I would want to look to (and which occupies a substantial portion of Chisum § 7.04, the section on the written description requirement). [read post]
16 Dec 2013, 1:23 pm
Similarly in Actavis v Eli Lilly [2013] EWCA Civ 517, the Court of Appeal confirmed that the English courts have jurisdiction to hear claims for declarations of non-infringement in relation to foreign designations of European patents where there is no challenge to validity. [read post]
12 Mar 2013, 5:43 pm
Eli Lilly & Co., 598 F.3d 1336, 1340 (Fed. [read post]
25 Jun 2011, 4:55 am
See Eli Lilly & Co. v. [read post]
18 May 2011, 12:33 am
General New texts in play in WIPO traditional knowledge, genetic resources talks (IP Watch) World Health Assembly to address organisational reform, IP issues (IP Watch) Australia: Therapeutic Goods Legislation Amendment (Copyright) Bill 2011 passed unamended (IP Whiteboard) EU: AG Bot says, it’s not the re-boxer who matters but the boss: C? [read post]
10 Feb 2025, 6:48 am
Lilly, however, is not involved in the case. [read post]
4 Aug 2022, 7:54 pm
Lilly, on the other hand, sought vindication of its copay program in court, possibly because Lilly thought the facts of the case painted a picture that seemed to show anything but corrupt or bad intent. [read post]
7 Jul 2008, 10:59 am
Eli Lilly & Co., No. 181/07, Ontario Superior Court of Justice, Divisional Court (Toronto) (July 2, 2008). [read post]
5 Nov 2017, 3:10 pm
Expectation of success argued Lilly, was a "critical consideration in all "obvious to try" cases. [read post]
17 May 2021, 12:45 am
Since the combination could not be deduced directly and unambiguously, implicitly or explicitly, from the original and divisional application, the claims were invalid due to added matter. 2. [read post]
1 Dec 2017, 6:20 am
The Swiss Federal Patent court had originally denied the infringement of Eli Lilly's patent but the Supreme Court granted Eli Lilly, a remarkable event in itself. [read post]
7 Sep 2011, 8:07 am
Drugmaker Eli Lilly unsuccessfully brought a similar action in South Carolina a few years ago. [read post]
26 Feb 2019, 9:00 am
Eli Lilly & Co., 119 F.3d 1559, 1564–65 (Fed. [read post]
5 Jul 2020, 5:43 am
This allows the organization to provide fair and balanced opinions on IP matters. [read post]
14 Oct 2015, 10:21 am
Larry Welch (Eli Lilly)Larry Welch from Eli Lilly concluded the presentation by outlining the position under US law which is simple - there is no requirement to remunerate inventors under US law. [read post]
4 Feb 2019, 2:01 am
The new year sees the issue of yet another UK court case applying the doctrine of equivalents as established by the UK Supreme Court in Actavis v Eli Lilly ([2017] UKSC 48) ("Actavis"). [read post]
7 Aug 2019, 12:43 am
", GuestKat Rose Hughes analyses the recent example of patent cases coming before the UK courts on the topic of growing clinical and economic significance of antibody-based therapeutics.Rose Hughes also looks at the recent press release on the opinion of the Enlarged Board of Appeal in G 1/18 here.In Beyond exclusion of pharmaceutical products from patentable subject matter as a solution to limited access to medicines in Africa. [read post]
1 Mar 2013, 11:56 am
Eli Lilly and CompanyCase number: 12-cv-2045 (United States District Court for the District of Columbia)Case filed: December 20, 2012Qualifying judgment/order: January 2, 2013 02/08/2013 05/09/2013 2013-13 SEC v. [read post]
3 Dec 2009, 9:45 am
Lilly would have been unreasonable as a matter of the administration of justice in that there seems no persuasive reason in the first place to believe the buyer. [read post]
